Cellectis Operating Cycle from 2010 to 2026

CLLS Stock  USD 4.40  0.14  3.08%   
Cellectis Operating Cycle yearly trend continues to be comparatively stable with very little volatility. Operating Cycle will likely drop to 173.21 in 2026. From the period from 2010 to 2026, Cellectis Operating Cycle quarterly data regression had r-value of  0.29 and coefficient of variation of  252.76. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
182.33
Current Value
173.21
Quarterly Volatility
2.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 24 M, Interest Expense of 9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 3.12, Dividend Yield of 0.0 or PTB Ratio of 1.26. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Build AI portfolio with Cellectis Stock
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Cellectis SA over the last few years. It is Cellectis' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Cellectis Operating Cycle Regression Statistics

Arithmetic Mean1,107
Geometric Mean259.67
Coefficient Of Variation252.76
Mean Deviation1,584
Median182.33
Standard Deviation2,799
Sample Variance7.8M
Range11.1K
R-Value0.29
Mean Square Error7.6M
R-Squared0.09
Significance0.25
Slope162.44
Total Sum of Squares125.3M

Cellectis Operating Cycle History

2026 173.21
2025 182.33
2024 202.59
202311.2 K
2022 4498.51
2021 100.5
2020 41.68

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 182.33  173.21 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.